Cancer Clinical Trials 2024

What are the top hospitals conducting cancer research?

When it comes to groundbreaking cancer research and clinical trials, several esteemed hospitals are at the forefront of innovation. One standout institution is Memorial Sloan Kettering Cancer Center in New york City. With an impressive 11 active cancer trials and a remarkable history of 260 completed trials since its first recorded trial in 1977, this center has been leading the charge against cancer for decades. In Boston, Massachusetts General Hospital is making significant contributions as well, currently conducting eight active cancer trials while having conducted an impressive total of 176 trials throughout its history since their first recorded trial in 1999.

One prominent facility that cannot be overlooked is The University of Texas MD Anderson Cancer Center located in Houston. This renowned center currently has eight active cancer trials underway and has accomplished an admirable tally of 88 previously conducted studies since initiating their inaugural trial in 2006. Additionally, GSK Investigational Site - Dallas also plays a vital role with its eight ongoing clinical tests for cancer treatment while holding a lesser but still important record with sixteen previous investigations dating back to their pioneering investigation on such cases starting only from2008

Lastly adding itself into this list we have GSK Investigational Site -Toronto where they too have same number(8)of ongoing clinical endeavors regarding potential solutions to combatting debilitating disease; they hold twenty-five prior experiments under their belt which began relatively recently just seven years ago during2014.

These top hospitals represent pillars of hope for patients affected by various forms of cancer across the country and beyond. Their unwavering dedication towards understanding this complex disease brings us one step closer to finding more effective treatments and ultimately achieving breakthroughs that will transform lives worldwide

Which are the best cities for cancer clinical trials?

Houston, Texas; New york, New York; Boston, Massachusetts; Nashville, Tennessee; and Toronto, Ontario emerge as the top cities for cancer clinical trials. Houston takes the lead with 50 active trials investigating treatments like SAR443216-Dose Expansion for metastatic gastric cancers with low HER2 expression and Metformin. Meanwhile, New York follows closely behind with 47 ongoing studies exploring novel approaches such as JAKi Naïve Combination Arm and Gene-modified T cell therapy. Similarly, Boston showcases its research prowess through 33 active trials focusing on advancements like P-PSMA-101 CAR-T cells. Additionally, Nashville hosts 27 clinical trials studying therapies like Cetuximab and CYNK-001 while Toronto contributes significantly to the field with its involvement in 25 active trials assessing agents such as CC-95251 and Ipilimumab. These cities serve as hubs of cutting-edge research that offer hope to cancer patients seeking innovative treatment options.

Which are the top treatments for cancer being explored in clinical trials?

Cutting-edge clinical trials are currently exploring a range of top treatments for cancer. Gemcitabine, known for its effectiveness, is being tested in two active trials and has an impressive track record with 81 all-time cancer trials since its first listing in 2001. Another promising candidate is EMB-01, which has shown potential in two ongoing trials and was introduced to the medical community in 2018 alongside BI 907828. Equally noteworthy is ATLCAR.CD30 cells, making waves since its debut on the scene in 2016 with two active and two all-time cancer trials. These innovative therapies offer hope as researchers continue their quest to conquer this complex disease.

What are the most recent clinical trials for cancer?

Exciting progress is being made in the field of cancer research with recent clinical trials offering hope for improved treatments. These include a Phase 1 trial exploring Part B Expansion, which became available on 8/10/2023. Additionally, a Phase 2 trial investigating Arm 1 and its potential benefits for cancer patients was released on 8/2/2023. Another noteworthy study is the Phase 2 Expansion Triplet combination that became available on 7/28/2023, showing promising outcomes in treating cancer. Moreover, VIP236 has shown promise as a potential treatment option in the Dose Escalation phase of its Phase 1 trial starting from January earlier this year. Lastly, there is an ongoing advanced solid tumors study encompassing both Phases 1 and 2 since January to explore novel therapies for these types of cancers. With continued dedication to advancing our understanding and treatment options, we are optimistic about improving outcomes for individuals affected by cancer.

What cancer clinical trials were recently completed?

Numerous innovative clinical trials targeting various types of cancer have recently concluded, signifying significant progress in the field. Among these groundbreaking studies, noteworthy completed trials include pegsitacianine by OncoNano Medicine, Inc., 64Cu-SAR-bisPSMA by Clarity Pharmaceuticals Ltd., ADG116 by Adagene Inc., Pembrolizumab by HiberCell, Inc., Capivasertib by AstraZeneca, and MRTX849 by Mirati Therapeutics Inc. These recent advancements demonstrate the commitment of researchers to finding effective treatments for cancer and offer hope for patients across the globe.